Algen Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
- Revenue Growth 54.57%
- Profit Growth 10.09%
- Ebitda 91.05%
- Net Worth 20.93%
- Total Assets 6.71%
About Algen Remedies
Algen Remedies Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 February 2012 and has a history of 12 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Virender Miglani and Meenu Miglani serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24297DL2012PTC232187
-
Company No.
232187
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Feb 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Algen Remedies Private Limited offer?
Algen Remedies Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Protein Supplements, Amino Acids, Popular Category, Bone & Joint Care, Health Conditions, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Algen Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virender Miglani
|
Director | 29-Feb-2012 | Current |
|
Meenu Miglani
|
Director | 29-Feb-2012 | Current |
Financial Performance of Algen Remedies.
Algen Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.57% increase. The company also saw a substantial improvement in profitability, with a 10.09% increase in profit. The company's net worth Soared by an impressive increase of 20.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Algen Remedies?
In 2022, Algen Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2024 | Others | ₹6.00 M | Open |
How Many Employees Work at Algen Remedies?
Algen Remedies has a workforce of 3 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Algen Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Algen Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
